RU96122469A - Матричные гранулы продленного действия и способ их получения - Google Patents
Матричные гранулы продленного действия и способ их полученияInfo
- Publication number
- RU96122469A RU96122469A RU96122469/14A RU96122469A RU96122469A RU 96122469 A RU96122469 A RU 96122469A RU 96122469/14 A RU96122469/14 A RU 96122469/14A RU 96122469 A RU96122469 A RU 96122469A RU 96122469 A RU96122469 A RU 96122469A
- Authority
- RU
- Russia
- Prior art keywords
- matrix granules
- prolonged action
- paragraphs
- extrusion
- carried out
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title claims 6
- 239000011159 matrix material Substances 0.000 title claims 6
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 230000002035 prolonged Effects 0.000 claims 4
- 238000001125 extrusion Methods 0.000 claims 3
- 238000000465 moulding Methods 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003349 gelling agent Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920003176 water-insoluble polymer Polymers 0.000 claims 1
Claims (8)
1. Матричные гранулы продленного действия шарико- или чечевицеобразной формы с единым максимальным диаметром, составляющим 0,5 - 4 мм, состоящие из
а) 0,1 - 87 вес.% по меньшей мере одного биологически активного соединения;
б) 5 - 50 вес.% по меньшей мере одного водонерастворимого полимера;
в) 5 - 45 вес.% по меньшей мере одного липофильного компонента в качестве пластификатора полимера б);
г) 3 - 40 вес.% природного или полусинтетического гелеобразователя,
д) 0 - 50 вес.% одного или нескольких стандартных вспомогательных веществ.
а) 0,1 - 87 вес.% по меньшей мере одного биологически активного соединения;
б) 5 - 50 вес.% по меньшей мере одного водонерастворимого полимера;
в) 5 - 45 вес.% по меньшей мере одного липофильного компонента в качестве пластификатора полимера б);
г) 3 - 40 вес.% природного или полусинтетического гелеобразователя,
д) 0 - 50 вес.% одного или нескольких стандартных вспомогательных веществ.
2. Матричные гранулы продленного действия по п. 1, отличающиеся следующими концентрациями компонентов:
а) 1 - 75 вес.%,
б) 10 - 40 вес.%,
в) 10 - 35 вес.%,
г) 5 - 25 вес.%,
д) 0 - 40 вес.%.
а) 1 - 75 вес.%,
б) 10 - 40 вес.%,
в) 10 - 35 вес.%,
г) 5 - 25 вес.%,
д) 0 - 40 вес.%.
3. Матричные гранулы продленного действия по п. 1 или 2, отличающиеся тем, что максимальный диаметр составляет 0,8 - 2 мм.
4. Матричные гранулы продленного действия по одному из пп. 1 - 3, отличающиеся тем, что активное начало (а) по своей природе является фармацевтическим.
5. Непрерывный, одностадийный способ получения матричных гранул продленного действия по одному из пп. 1 - 4 путем экструзии расплавленной смеси компонентов при 50 - 200°С и непрерывного формования.
6. Способ по п. 5, отличающийся тем, что экструзию проводят при 50 - 180°С.
7. Способ по п. 5, отличающийся тем, что экструзию проводят при 60 - 150°С.
8. Способ по одному из пп. 5 - 7, отличающийся тем, что формование осуществляют путем обрезания в горячем состоянии.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4413350A DE4413350A1 (de) | 1994-04-18 | 1994-04-18 | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
DEP4413350.2 | 1994-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96122469A true RU96122469A (ru) | 1999-01-20 |
RU2155031C2 RU2155031C2 (ru) | 2000-08-27 |
Family
ID=6515707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96122469/14A RU2155031C2 (ru) | 1994-04-18 | 1995-04-05 | Матричные гранулы продленного действия |
Country Status (23)
Country | Link |
---|---|
US (1) | US6290990B1 (ru) |
EP (1) | EP0756480B1 (ru) |
JP (1) | JP4099225B2 (ru) |
KR (1) | KR100371885B1 (ru) |
CN (1) | CN1131024C (ru) |
AT (1) | ATE204747T1 (ru) |
AU (1) | AU2256495A (ru) |
BR (1) | BR9507328A (ru) |
CA (1) | CA2188185C (ru) |
CZ (1) | CZ301396A3 (ru) |
DE (2) | DE4413350A1 (ru) |
DK (1) | DK0756480T3 (ru) |
ES (1) | ES2162635T3 (ru) |
FI (1) | FI964175A (ru) |
HU (1) | HU221981B1 (ru) |
IL (1) | IL113316A (ru) |
MX (1) | MXPA96004911A (ru) |
NO (1) | NO313735B1 (ru) |
NZ (1) | NZ284064A (ru) |
PL (1) | PL317936A1 (ru) |
PT (1) | PT756480E (ru) |
RU (1) | RU2155031C2 (ru) |
WO (1) | WO1995028147A1 (ru) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656290A (en) * | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US5965161A (en) † | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
DE19531277A1 (de) * | 1995-08-25 | 1997-02-27 | Basf Ag | Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren |
DE19539362A1 (de) * | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von festen Arzneiformen |
DE19539360A1 (de) * | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von festen Arzneiformen |
FR2748209B1 (fr) * | 1996-05-06 | 1998-06-05 | Adir | Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs |
DE19637082A1 (de) | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
US8828432B2 (en) * | 1996-10-28 | 2014-09-09 | General Mills, Inc. | Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles |
FR2761605B1 (fr) * | 1997-04-07 | 2001-02-23 | Prographarm Lab | Forme pharmaceutique multiparticulaire, ses particules constitutives, procede et installation pour leur fabrication |
AU747549B2 (en) * | 1998-03-23 | 2002-05-16 | General Mills Inc. | Encapsulation of components into edible products |
DE19842753A1 (de) | 1998-09-18 | 2000-03-23 | Bayer Ag | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
BR0012869A (pt) | 1999-07-30 | 2002-05-21 | Smithkline Beecham Plc | Forma de dosagem farmacêutica de componentes múltiplos |
DE10045904B4 (de) * | 1999-10-01 | 2007-07-12 | Degussa Gmbh | alpha-Liponsäure(-Derivate) enthaltende Retardform |
ATE526950T1 (de) | 1999-10-29 | 2011-10-15 | Euro Celtique Sa | Hydrocodon-formulierungen mit gesteuerter freisetzung |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
JP5767429B2 (ja) * | 1999-11-12 | 2015-08-19 | アッヴィ・インコーポレイテッド | 固体分散剤中の結晶化阻害剤 |
US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
AU5066101A (en) * | 2000-04-13 | 2001-10-30 | Synthon B.V. | Modified release formulations containing a hypnotic agent |
DE10026698A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
EP2263658A1 (en) | 2000-10-30 | 2010-12-22 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US7883721B2 (en) | 2001-01-30 | 2011-02-08 | Smithkline Beecham Limited | Pharmaceutical formulation |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
US7842308B2 (en) * | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
US20030198671A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique plasma AUC properties |
DE10150938A1 (de) * | 2001-10-04 | 2003-04-24 | Frunol Delicia Gmbh | Schädlingsbekämpfungsmittel und Verfahren zu dessen Herstellung |
US20030180356A1 (en) * | 2001-10-29 | 2003-09-25 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
US7700134B2 (en) * | 2002-01-17 | 2010-04-20 | The Regents Of The University Of Michigan | Prevention of cisplatin induced deafness |
US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
US20050182056A9 (en) * | 2002-02-21 | 2005-08-18 | Seth Pawan | Modified release formulations of at least one form of tramadol |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
BR0312206A (pt) * | 2002-06-27 | 2005-04-12 | Cilag Ag | Formulações de pélete esférico |
US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
CA2491572C (en) * | 2002-07-05 | 2010-03-23 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
WO2004014318A2 (en) * | 2002-08-10 | 2004-02-19 | King Pharmaceuticals, Inc. | Levothyroxine compositions and methods |
DE10247037A1 (de) * | 2002-10-09 | 2004-04-22 | Abbott Gmbh & Co. Kg | Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers |
KR20040043589A (ko) * | 2002-11-19 | 2004-05-24 | 경동제약 주식회사 | 서방성 세파클러 제제 및 그 제조방법 |
SI21353A (sl) * | 2002-11-27 | 2004-06-30 | Lek farmacevtska družba, d.d. | Pelete vsebujoče brezvodne tekočine in proces njihove priprave |
ES2208123A1 (es) * | 2002-11-29 | 2004-06-01 | Laboratorios Del Dr. Esteve, S.A. | Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento. |
ES2208124B1 (es) * | 2002-11-29 | 2005-10-01 | Laboratorios Del Dr. Esteve, S.A. | Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento. |
DK1590144T3 (en) * | 2002-12-10 | 2015-11-09 | Nortec Dev Ass | Process for preparing biologically active formulations |
WO2004064807A1 (en) * | 2003-01-23 | 2004-08-05 | Amorepacific Corporation | Sustained-release preparations and method for producing the same |
US20070059358A1 (en) * | 2003-07-02 | 2007-03-15 | Tianjin Tasly Pharmaceutical Co., Ltd., China | Matrix adjuvants and the drop pills prepared with them |
TW200526274A (en) | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
TWI350762B (en) * | 2004-02-12 | 2011-10-21 | Euro Celtique Sa | Particulates |
GB0403098D0 (en) * | 2004-02-12 | 2004-03-17 | Euro Celtique Sa | Extrusion |
AR048033A1 (es) | 2004-03-12 | 2006-03-22 | Smithkline Beecham Plc | Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion |
SI1765292T1 (en) | 2004-06-12 | 2018-04-30 | Collegium Pharmaceutical, Inc. | Formulations of medicines to discourage abuse |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
WO2006009403A1 (en) * | 2004-07-22 | 2006-01-26 | Amorepacific Corporation | Sustained-release preparations containing topiramate and the producing method thereof |
ATE497995T1 (de) * | 2004-12-27 | 2011-02-15 | Kaneka Corp | Thermoplastharzzusammensetzung |
JP5185534B2 (ja) * | 2004-12-27 | 2013-04-17 | 株式会社カネカ | 凝固ラテックス粒子の製造方法 |
US20070270539A1 (en) * | 2004-12-27 | 2007-11-22 | Koji Yui | Thermoplastic Resin Composition |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US7803413B2 (en) * | 2005-10-31 | 2010-09-28 | General Mills Ip Holdings Ii, Llc. | Encapsulation of readily oxidizable components |
US20070184163A1 (en) * | 2006-02-07 | 2007-08-09 | International Flavors, & Fragrances Inc. | Non-hygroscopic flavor particles |
EP2010158B1 (en) * | 2006-04-26 | 2016-02-17 | Alphapharm Pty Ltd. | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
EP2144599B1 (en) * | 2007-03-02 | 2010-08-04 | Farnam Companies, Inc. | Sustained release pellets comprising wax-like material |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
EP2219624A2 (en) | 2007-11-08 | 2010-08-25 | Glaxo Group Limited | Pharmaceutical formulations |
WO2009088318A1 (ru) * | 2007-12-29 | 2009-07-16 | Physics Depertment M.V. Lomonosov Moscow State University | Магнитные полимерные гранулы и способы их применения |
CA2710986A1 (en) * | 2007-12-29 | 2009-07-16 | Physics Department M.V. Lomonosov Moscow State University | Magnetic polymer pellets and a method of generating the blocking gel plug |
BRPI0906467C1 (pt) | 2008-01-25 | 2021-05-25 | Gruenenthal Gmbh | forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada |
KR101094231B1 (ko) * | 2008-02-18 | 2011-12-14 | 하나제약 주식회사 | 서방성 고형 제제 및 그의 제조방법 |
KR101690094B1 (ko) | 2008-05-09 | 2016-12-27 | 그뤼넨탈 게엠베하 | 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법 |
MX2011000825A (es) * | 2008-07-22 | 2011-02-25 | Gen Mills Inc | Productos frutales que contienen acidos grasos omega-3. |
EP2437616A4 (en) * | 2009-06-05 | 2013-08-21 | Gen Mills Inc | ENCAPSULATED OMEGA-3 FATTY ACIDS FOR THE MANUFACTURE OF BAKERY PRODUCTS |
PE20121067A1 (es) | 2009-07-22 | 2012-09-05 | Gruenenthal Chemie | Forma de dosificacion de liberacion controlada extruida por fusion en caliente |
WO2011009604A1 (en) | 2009-07-22 | 2011-01-27 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
CA2782556C (en) | 2009-12-02 | 2018-03-27 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
JP2013526523A (ja) | 2010-05-11 | 2013-06-24 | シマ ラブス インク. | メトプロロールを含むアルコール耐性持続放出性経口剤形 |
WO2012028319A1 (en) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
CA2808541C (en) | 2010-09-02 | 2019-01-08 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
DE102011018403A1 (de) * | 2011-04-21 | 2012-10-25 | Automatik Plastics Machinery Gmbh | Verfahren zur Herstellung von pharmazeutischen Erzeugnissen aus einem Schmelzematerial |
AR087360A1 (es) | 2011-07-29 | 2014-03-19 | Gruenenthal Gmbh | Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato |
KR20140053158A (ko) | 2011-07-29 | 2014-05-07 | 그뤼넨탈 게엠베하 | 즉시 약물 방출을 제공하는 탬퍼-저항성 정제 |
CA2864949A1 (en) | 2012-02-28 | 2013-09-06 | Grunenthal Gmbh | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
JP6282261B2 (ja) | 2012-04-18 | 2018-02-21 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 不正使用防止および過量放出防止医薬剤形 |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
CA2913209A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper resistant dosage form with bimodal release profile |
EP3003279A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
RU2535049C1 (ru) * | 2013-07-11 | 2014-12-10 | Общество с ограниченной ответственностью "КОМПАНИЯ "ДЕКО" | Способ получения стабилизированной субстанции дротаверина гидрохлорида |
AU2014289187B2 (en) | 2013-07-12 | 2019-07-11 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
US20150118300A1 (en) | 2013-10-31 | 2015-04-30 | Cima Labs Inc. | Immediate Release Abuse-Deterrent Granulated Dosage Forms |
MX371372B (es) | 2013-11-26 | 2020-01-28 | Gruenenthal Gmbh | Preparacion de una composicion farmaceutica en polvo por medio de criomolienda. |
CA2947786A1 (en) | 2014-05-12 | 2015-11-19 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising tapentadol |
WO2015181059A1 (en) | 2014-05-26 | 2015-12-03 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
JP2018517676A (ja) | 2015-04-24 | 2018-07-05 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 即時放出および溶媒抽出に対する耐性を有する改変防止製剤 |
WO2017042325A1 (en) | 2015-09-10 | 2017-03-16 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
CN111372578A (zh) | 2017-08-24 | 2020-07-03 | 阿达玛斯药物有限责任公司 | 金刚烷胺组合物、其制备和使用方法 |
EP3965733A4 (en) | 2019-05-07 | 2023-01-11 | Clexio Biosciences Ltd. | ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
CN116098871A (zh) * | 2022-12-16 | 2023-05-12 | 深圳市瑞华制药技术有限公司 | 一种美沙拉秦缓释颗粒的制备工艺 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL297357A (ru) | 1962-08-31 | |||
US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
FR2581541B1 (fr) * | 1985-05-09 | 1988-05-20 | Rhone Poulenc Sante | Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation |
DE3612212A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
DE3612211A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
US5326572A (en) * | 1989-03-23 | 1994-07-05 | Fmc Corporation | Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions |
US4983399A (en) * | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
WO1993007859A1 (en) * | 1991-10-23 | 1993-04-29 | Warner-Lambert Company | Novel pharmaceutical pellets and process for their production |
DE4138513A1 (de) | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
-
1994
- 1994-04-18 DE DE4413350A patent/DE4413350A1/de not_active Withdrawn
-
1995
- 1995-04-05 BR BR9507328A patent/BR9507328A/pt not_active Application Discontinuation
- 1995-04-05 CZ CZ963013A patent/CZ301396A3/cs unknown
- 1995-04-05 PT PT95915844T patent/PT756480E/pt unknown
- 1995-04-05 RU RU96122469/14A patent/RU2155031C2/ru active
- 1995-04-05 CA CA002188185A patent/CA2188185C/en not_active Expired - Lifetime
- 1995-04-05 EP EP95915844A patent/EP0756480B1/de not_active Expired - Lifetime
- 1995-04-05 ES ES95915844T patent/ES2162635T3/es not_active Expired - Lifetime
- 1995-04-05 JP JP52666695A patent/JP4099225B2/ja not_active Expired - Fee Related
- 1995-04-05 DK DK95915844T patent/DK0756480T3/da active
- 1995-04-05 NZ NZ284064A patent/NZ284064A/en unknown
- 1995-04-05 HU HU9602878A patent/HU221981B1/hu active IP Right Grant
- 1995-04-05 PL PL95317936A patent/PL317936A1/xx unknown
- 1995-04-05 CN CN95192933A patent/CN1131024C/zh not_active Expired - Lifetime
- 1995-04-05 AT AT95915844T patent/ATE204747T1/de active
- 1995-04-05 MX MXPA96004911A patent/MXPA96004911A/es active IP Right Grant
- 1995-04-05 AU AU22564/95A patent/AU2256495A/en not_active Abandoned
- 1995-04-05 DE DE59509563T patent/DE59509563D1/de not_active Expired - Lifetime
- 1995-04-05 WO PCT/EP1995/001236 patent/WO1995028147A1/de active IP Right Grant
- 1995-04-05 KR KR1019960705854A patent/KR100371885B1/ko not_active IP Right Cessation
- 1995-04-11 IL IL11331695A patent/IL113316A/xx not_active IP Right Cessation
- 1995-04-15 US US08/727,666 patent/US6290990B1/en not_active Expired - Lifetime
-
1996
- 1996-10-17 NO NO19964410A patent/NO313735B1/no not_active IP Right Cessation
- 1996-10-17 FI FI964175A patent/FI964175A/fi unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU96122469A (ru) | Матричные гранулы продленного действия и способ их получения | |
BR9507328A (pt) | Pelotas de matriz de lenta liberaçãco e processo em um estágio continuo para produzir as mesma | |
RS50054B (sr) | Kompozicije oksikodona sa kontrolisanim oslobađanjem | |
CA2046679A1 (en) | Pharmaceutical composition for rapid suspension in water | |
SE8405615L (sv) | Farmaceutiska tabletter med depaverkan och forfarande for deras framstellning | |
ATE123649T1 (de) | Feste pharmazeutische retardform. | |
ES535129A0 (es) | Un procedimiento para la obtencion de polimeros porosos reticulados para liberacion controlada de farmacos | |
DE3883251D1 (de) | Latex enthaltende agrochemische zusammensetzungen. | |
KR900700021A (ko) | 냉동 분쇄 어육 첨가용 품질 개량제 및 이것을 사용한 냉동 분쇄어육의 제조방법 | |
CA1261271A (en) | Solid medicament formulation containing nitrendipine and a process for its preparation | |
EA199700093A1 (ru) | ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК | |
IE870064L (en) | Sustained release capsule | |
EA200100491A1 (ru) | Покрытые оболочкой частицы гранулированного кристаллического ибупрофена | |
PT87404A (pt) | Process for the preparation of an additive for the fire extinction water containing high polymers | |
EP0297866A3 (en) | Therapeutic agents | |
KR840004347A (ko) | 불안정한 약물 또는 음식물 첨가물의 안정화 | |
RU2001124607A (ru) | Составы на основе бетагистина с контролируемым высвобождением | |
DK136487A (da) | Farmaceutisk praeparat indeholdende ibuprofen og fremgangsmaade til fremstilling deraf | |
KR890007745A (ko) | 약학조성물 및 그의 제조방법 | |
KR900007763A (ko) | 서방성 옥사미드 비료 및 그 제조방법 | |
JPS52141852A (en) | Synthetic resin composition | |
JPS6430A (en) | Gradually releasing preparation | |
KR910002358A (ko) | 중체량(weight gain)-증가제 | |
YU130890A (sh) | Postupak za pravljenje čvrstog farmaceutskog preparata za oslobadjanje aktivne supstance | |
JPS57189647A (en) | Assorted feed for aquatic animal |